Michael R. Bristow, Chief Science & Medical Officer at MYOGEN INC (MYOG), sold 30,000 shares at $30.14 ($903K) on 2006-01-03, disclosed to the SEC on 2006-01-09.
Scheduled sale ($903k) by Chief Science & Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $30.03 | 5,000 | $150K | 16.6% |
| 2 | $30.07 | 2,500 | $75K | 8.3% |
| 3 | $30.14 | 22,500 | $678K | 75.1% |
| Total | $30.12 avg | 30,000 | $903K | 100% |
| Filing → |
| ABIO | SELL | 2016-09-21 | $6K | — | Filing → |
| ABIO | SELL | 2016-04-06 | $3K | — | Filing → |
| ABIO | SELL | 2016-03-02 | $3K | — | Filing → |